Vimarsana
Biggest News Aggregation in the World

Belgian Act News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Belgian Act. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Belgian Act Today - Breaking & Trending Today

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas - Vimarsana News

Oxurion NV: Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas Atlas Special Opportunities, LLC has converted 8 convertible bonds in Oxurion resulting in a EUR

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ... - Vimarsana News

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from ...

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas

Nyxoah Announces Proposed Offering of Ordinary Shares - Vimarsana News

Nyxoah Announces Proposed Offering of Ordinary Shares

REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium - May 22, 2024, 10:05pm CET / 4:05pm ET - Nyxoah SA (Euronext Brussels/Nasdaq:

Aedifica : Draft amendment Coordinated Articles of Association - 04/04/2024 -April 04, 2024 at 12:38 am EDT - Vimarsana News

Aedifica : Draft amendment Coordinated Articles of Association - 04/04/2024 -April 04, 2024 at 12:38 am EDT

Proposed changes to the Articles of Association AEDIFICA Public regulated real estate company under Belgian law or...

Transparency Notifications from Shareholders - Vimarsana News

Transparency Notifications from Shareholders

PRESS RELEASEREGULATED INFORMATION3 April 2024, 06:00 pm CEST Ghent, Belgium – 3 April 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, announces today that it received transparency notifications from the shareholders listed below, notifying the number of voting rights attached to shares mentioned next to their respective names in the table below. The transparency no

Source: yahoo.com